← All trials
NCT02344810
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2015
- Primary completion
- Jun 1, 2016
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 308
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Eastern Cooperative Oncology GroupLead sponsor
- ECOG-ACRIN Cancer Research GroupOverall official - principal investigator
- National Cancer Institute (NCI)Collaborator
- ECOG-ACRIN Cancer Research GroupCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.